Yichen Zhu

727 total citations · 2 hit papers
18 papers, 351 citations indexed

About

Yichen Zhu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yichen Zhu has authored 18 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Yichen Zhu's work include CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (6 papers). Yichen Zhu is often cited by papers focused on CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (6 papers). Yichen Zhu collaborates with scholars based in United States. Yichen Zhu's co-authors include Lili Yang, Yan-Ruide Li, Ying Fang, Matthew Wilson, Adam B. Kramer, Kuangyi Zhou, Yanqi Yu, Yuning Chen, James Brown and Derek Lee and has published in prestigious journals such as Cell, Nature Communications and Nature Nanotechnology.

In The Last Decade

Yichen Zhu

17 papers receiving 347 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies

2025 23 citations Yan-Ruide Li, Ying Fang et al. Nature Communications profile →
Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

2025 18 citations Miao Li, Enbo Zhu et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yichen Zhu United States	12	233	152	104	53	27	18	351
Tamara Muliaditan United Kingdom	6	179 0.8×	163 1.1×	133 1.3×	54 1.0×	34 1.3×	6	327
Monika A. Eiva United States	4	185 0.8×	195 1.3×	72 0.7×	50 0.9×	23 0.9×	6	290
Davide Bernareggi United States	5	254 1.1×	265 1.7×	144 1.4×	34 0.6×	24 0.9×	12	410
Nancy P. Kren United States	7	255 1.1×	167 1.1×	79 0.8×	83 1.6×	53 2.0×	7	338
Katerina Goudevenou United Kingdom	5	217 0.9×	165 1.1×	92 0.9×	23 0.4×	31 1.1×	10	298
Tanakorn Srirat Japan	7	195 0.8×	176 1.2×	102 1.0×	32 0.6×	41 1.5×	8	323
Nicole Gaulin United States	3	294 1.3×	299 2.0×	80 0.8×	25 0.5×	22 0.8×	6	390
Nicole Milenkovski Canada	4	239 1.0×	197 1.3×	79 0.8×	32 0.6×	14 0.5×	4	368
Maryann Mikucki United States	4	312 1.3×	314 2.1×	131 1.3×	40 0.8×	25 0.9×	5	467
Ramizah Syahirah United States	8	117 0.5×	187 1.2×	125 1.2×	82 1.5×	28 1.0×	11	329

Countries citing papers authored by Yichen Zhu

Since Specialization

Citations

This map shows the geographic impact of Yichen Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichen Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichen Zhu more than expected).

Fields of papers citing papers by Yichen Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichen Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichen Zhu. The network helps show where Yichen Zhu may publish in the future.

Co-authorship network of co-authors of Yichen Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yichen Zhu. A scholar is included among the top collaborators of Yichen Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichen Zhu. Yichen Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Fang, Ying, et al.. (2025). Protocol to generate allorejection-resistant universal CAR-NKT cells and evaluate their efficacy, mechanism of action, safety, and immunogenicity. STAR Protocols. 6(2). 103810–103810. 1 indexed citations

Li, Yan-Ruide, et al.. (2025). Emerging trends in clinical allogeneic CAR cell therapy. Med. 6(8). 100677–100677. 10 indexed citations

Li, Yan-Ruide, Kuangyi Zhou, Yichen Zhu, et al.. (2025). Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture. Nature Protocols. 20(5). 1352–1388. 12 indexed citations

Zhu, Yichen, Zhe Li, Aiqi Zhao, et al.. (2025). Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety. Molecular Therapy. 33(12). 6041–6062. 3 indexed citations

Li, Yan-Ruide, Yichen Zhu, & Lili Yang. (2025). Clinical technology advances driving in vivo CAR therapy. Trends in biotechnology.

Li, Yan-Ruide, Ying Fang, Yichen Zhu, et al.. (2025). Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies. Nature Communications. 16(1). 1248–1248. 23 indexed citations breakdown →

Li, Miao, Enbo Zhu, Zhe Li, et al.. (2025). Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis. Cell. 188(14). 3823–3842.e21. 18 indexed citations breakdown →

Zhu, Enbo, Jiaji Yu, Yan-Ruide Li, et al.. (2024). Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies. Nature Nanotechnology. 19(12). 1914–1922. 12 indexed citations

Li, Yan-Ruide, et al.. (2024). Breaking the mold: Unconventional T cells in cancer therapy. Cancer Cell. 43(3). 317–322. 16 indexed citations

10.

Fang, Ying, et al.. (2023). Graft-versus-Host Disease Modulation by Innate T Cells. International Journal of Molecular Sciences. 24(4). 4084–4084. 10 indexed citations

11.

Li, Yan-Ruide, et al.. (2023). Advancements in CRISPR screens for the development of cancer immunotherapy strategies. Molecular Therapy — Oncolytics. 31. 100733–100733. 10 indexed citations

12.

Chen, Yuning, Yichen Zhu, Adam B. Kramer, et al.. (2023). Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy. Frontiers in Medicine. 10. 1135468–1135468. 12 indexed citations

13.

Li, Yan-Ruide, Yichen Zhu, Adam B. Kramer, et al.. (2023). Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design. iScience. 26(10). 107952–107952. 14 indexed citations

14.

Li, Yan-Ruide, et al.. (2023). Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. Journal of Translational Medicine. 21(1). 686–686. 76 indexed citations

15.

Li, Yan-Ruide, Kuangyi Zhou, Matthew Wilson, et al.. (2022). Mucosal-associated invariant T cells for cancer immunotherapy. Molecular Therapy. 31(3). 631–646. 45 indexed citations

16.

Li, Yan-Ruide, James Brown, Yanqi Yu, et al.. (2022). Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity. Cancers. 14(11). 2749–2749. 48 indexed citations

17.

Li, Yan-Ruide, Yang Zhou, Matthew Wilson, et al.. (2022). Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity against Solid Tumors. International Journal of Molecular Sciences. 23(14). 7547–7547. 11 indexed citations

18.

Zhu, Yichen, et al.. (2022). 3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy. MDPI (MDPI AG). 1(2). 149–167. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact